A comprehensive view of Approved Drugs / Devices. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
AbbVie gains European Commission approval for SKYRIZI® to treat moderate to severe ulcerative colitis in adults; supported by two pivotal Phase 3 trials showing clinical remission
Published:
July 26, 2024
by AbbVie Inc.
|
European Commission approves Pfizer's DURVEQTIX® gene therapy for hemophilia B; reduces bleeds post-treatment with a median annualized bleed rate of zero bleeds after up to four years of follow-up
Published:
July 25, 2024
by Pfizer Inc.
|
GlobalData: FDA approves OTC continuous glucose monitors from Dexcom and Abbott, designed for individuals who don't use insulin; high prediabetes prevalence expected to drive global market of OTC CGMs to reach US$5.1B by 2033
Published:
July 23, 2024
by GlobalData Plc
|
Johnson & Johnson seeks FDA approval for depression nasal spray monotherapy; J&J aims to expand Spravato's indication for treatment-resistant depression in adults
Published:
July 22, 2024
by FiercePharma
|
Roche's Susvimo shows sustained efficacy over two years in Phase III diabetic eye studies; FDA accepts application for diabetic macular edema and retinopathy treatments based on one-year results
Published:
July 18, 2024
by F. Hoffmann-La Roche Ltd. (Roche)
|
Ask us about our Bioeconomy market view
Trending Chart
Interactive chart with headline count